Clinical trials in Leidschendam – page 101

1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in the NetherlandsKlinischOnderzoek.nl

Leidschendam at a glance

1 919

clinical trials

Research sites1

Quick filters

1 919 trials in Leidschendam

Open in trial search

Prostate cancer

Not recruiting

Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

Registered drugNo placebo

Study on the Use of 18F-PSMA-1007, Piflufolastat (18F), and Gozetotide for Detecting Pelvic Lymph Node Invasion in Newly Diagnosed Prostate Cancer Patients

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Gozetotide
Sponsor:Canisius Wilhelmina Ziekenhuis

Contact Research Centre

Bladder transitional cell carcinoma

Not recruiting

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

Study of Eciskafusp Alfa and BCG for Patients with High-Risk Bladder Cancer Not Responding to BCG Treatment

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:RO7284755
Sponsor:F. Hoffmann-La Roche AG

Contact Research Centre

Neoplasm+1

Not recruiting

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

InvestigationalNo placebo

Study on the Safety and Effects of VERT-002 for Patients with Advanced Solid Tumors, Including Lung Cancer with MET Alterations

InvestigationalNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:VERT-002
Sponsor:Pierre Fabre Medicament

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Study of Galunisertib and Capecitabine for Patients with Advanced Chemotherapy-Resistant Colorectal Cancer with Peritoneal Metastases

Registered drugNo placebo

Study of Galunisertib and Capecitabine for Patients with Advanced Chemotherapy-Resistant Colorectal Cancer with Peritoneal Metastases

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Capecitabine
Sponsor:Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting

Contact Research Centre

Cardiac amyloidosis

Not recruiting

Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

Registered drugNo placebo

Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Vutrisiran
Sponsor:Alnylam Pharmaceuticals Inc.

Contact Research Centre

Fibromyalgia

Not recruiting

Study on Psilocybin's Effect on Pain in Fibromyalgia Patients

Investigational

Study on Psilocybin's Effect on Pain in Fibromyalgia Patients

Investigational

The Netherlands

Participants:18–64 years
Substances:Psilocybine
Sponsor:Universiteit Maastricht

Contact Research Centre

Type IIa hyperlipidaemia

Not recruiting

Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia

Registered drug

Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia

Registered drug

The Netherlands

Participants:0–17 years
Substances:Inclisiran
Sponsor:Novartis Pharma AG

Contact Research Centre

Adrenoleukodystrophy+1

Not recruiting

Study on Pramipexole for Treating Restless Legs in Women with X-linked Adrenoleukodystrophy

Registered drugNo placebo

Study on Pramipexole for Treating Restless Legs in Women with X-linked Adrenoleukodystrophy

Registered drugNo placebo

The Netherlands

Participants:18–64 years · 65+ years
Substances:Pramipexole Dihydrochloride Monohydrate
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Hormone-refractory prostate cancer+1

Not recruiting

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug

Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

Registered drug

The Netherlands

Participants:18–64 years · 65+ years
Substances:Enzalutamide
Sponsor:Pfizer Inc.

Contact Research Centre

Depression

Not recruiting

Study on Improving ECT Response and Reducing Cognitive Side Effects in Depression Patients Using Rivastigmine

Registered drug

Study on Improving ECT Response and Reducing Cognitive Side Effects in Depression Patients Using Rivastigmine

Registered drug

The Netherlands

Participants:18–64 years
Substances:Rivastigmine
Sponsor:Universitair Medisch Centrum Groningen

Contact Research Centre

Fibrodysplasia ossificans progressiva

Not recruiting

Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

Investigational

Study on the Safety and Effects of Saracatinib for Patients with Fibrodysplasia Ossificans Progressiva (FOP)

Investigational

The Netherlands

Participants:18–64 years
Substances:Saracatinib
Sponsor:Amsterdam UMC Stichting

Contact Research Centre

Obesity

Not recruiting

Study to Evaluate the Effectiveness of Survodutide in Reducing Liver Fat and Weight in Patients with Obesity or Overweight and Non-Alcoholic Steatohepatitis (NASH)

Investigational

Study to Evaluate the Effectiveness of Survodutide in Reducing Liver Fat and Weight in Patients with Obesity or Overweight and Non-Alcoholic Steatohepatitis (NASH)

Investigational

The Netherlands

Participants:18–64 years · 65+ years
Substances:Survodutide
Sponsor:Boehringer Ingelheim International GmbH

Contact Research Centre

Other cities in the Netherlands

The busiest research cities in the country

All 101 cities in the Netherlands

Clinical research in Leidschendam

What the registry says about research in the country

01 Oncology - Lung Cancer Research

Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.

Advanced NSCLC treatments
Immunotherapy combinations
KRAS G12C inhibitors

Studies compare various treatment options to improve patient outcomes and survival rates.

02 Breast Cancer Studies

Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.

Metastatic breast cancer
HER2-positive therapy
Triple-negative breast cancer

Trials examine innovative treatment strategies and personalized approaches.

03 Hematologic Malignancies

Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.

Advanced Hodgkin Lymphoma
Follicular Lymphoma
Treatment optimization

Research aims to improve treatment outcomes while minimizing toxicity.

04 Gastrointestinal Oncology

Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.

Rectal cancer treatments
Esophagogastric cancer
Surgical innovations

Focus on improving surgical outcomes and treatment effectiveness.

05 Brain Metastases Research

Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.

Radiation necrosis treatment
Metastatic detection
Targeted therapies

Research aims to improve detection and treatment of brain metastases.

Back to the Netherlands All countries